智通财经网·2025-08-04 09:36Core Viewpoint - UBS reports that the "anti-involution" movement in mainland China is expanding into various sectors, including healthcare and financial services, with analysts expressing skepticism about the potential impacts of these measures on the market [1][2] Group 1: Industry Impact - The "anti-involution" movement has shown varying intensity across different industries, with regulatory bodies urging companies in the food delivery and automotive sectors to rectify promotional behaviors and engage in rational competition [2] - In the solar industry, manufacturers are prohibited from selling below cost according to the Price Law, while in the coal sector, production is limited to 110% of total capacity across eight provinces [2] - The lithium industry is facing increased scrutiny over illegal mining activities, and in the pig farming sector, stricter capacity controls are being emphasized [2] - Overall, the current measures are considered less intense compared to interventions in 2014-2015 but cover a broader range of industries [2] Group 2: Investment Opportunities - UBS identifies key motivations behind these measures, including enhancing corporate profitability and government tax revenue domestically, and addressing international resistance to China's industrial overcapacity [3] - The firm believes that the risk is skewed to the upside, as average performance in related sectors has not significantly outperformed the market, and investor expectations are generally low [3] - UBS ranks sectors based on motivation, demand response, and market pricing, favoring solar, chemical, and lithium industries for investment [3] - Preferred stocks in the solar supply chain include GCL-Poly Energy (03800), Tongwei Co. (600438.SH), and LONGi Green Energy (601012.SH); in the chemical sector, Hualu Chemical (600426.SH) and Hengli Petrochemical (600346.SH) are favored; and in the lithium sector, Salt Lake Potash (000792.SZ) is highlighted [3]